I think that as we reflect on what was obviously a sad event reported by Pfizer yesterday ... decision along with discussions we've been having with FDA. You designate that as our pivotal dose. Yes, ...

Infectious disease experts predict another coronavirus pandemic in the future, so we need to be prepared. That will require both basic research to devise improved vaccines, including "universal" ones ...

An updated COVID booster ... dose. So far, the agency is not suggesting that younger people get a spring dose. The updated ...

Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase 3 clinical trial evaluating BNT323/DB-1303 in HR+ HER2-low chemotherapy- ...

A poorly framed article on people who believe that COVID-19 vaccines injured them is being trumpeted by antivaxxerst. Where ...

The change was mainly due to recognizing lower cost of sales from BioNTech’s decreased COVID-19 vaccine sales, which included the share of gross profit that BioNTech owes its collaboration partner ...

All vaccines have at least occasional side effects. But people who say they were injured by COVID vaccines believe their cases have been ignored.

2 This update is anticipated to be included in the recommended immunization schedule. Guidelines regarding the administration of a single booster dose of the Tdap vaccine among children aged between ...

A new meta-analysis of 16 studies reveals that, for pre-exposure prophylactic vaccination (PrEP, which is used for disease ...

Pfizer (NYSE:PFE) said it has received FDA approval for its one-time gene therapy Beqvez for the treatment of certain adults with hemophilia B. The drugmaker said the therapy is aimed at enabling ...

Pfizer (NYSE:PFE) said it has received FDA approval for its one-time gene therapy Beqvez for the treatment of certain adults with hemophilia B. The drugmaker said the therapy is aimed at enabling ...